Anhui Sunhere Pharmaceutical ExcipientsLtd Yönetim

Yönetim kriter kontrolleri 4/4

Anhui Sunhere Pharmaceutical ExcipientsLtd CEO'su Zheng Long Yin, Aug2009 tarihinde atandı, in görev süresi 15.25 yıldır. şirketin hisselerinin 27.11% doğrudan sahiptir ve bu hisselerin değeri CN¥ 776.24M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6.3 yıl ve 3.3 yıldır.

Anahtar bilgiler

Zheng Long Yin

İcra Kurulu Başkanı

CN¥910.9k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	15.3yrs
CEO sahipliği	27.1%
Yönetim ortalama görev süresi	6.3yrs
Yönetim Kurulu ortalama görev süresi	3.3yrs

Son yönetim güncellemeleri

Recent updates

Anhui Sunhere Pharmaceutical ExcipientsLtd's (SZSE:300452) Earnings Are Weaker Than They Seem

Sep 03

Anhui Sunhere Pharmaceutical ExcipientsLtd (SZSE:300452) Has Affirmed Its Dividend Of CN¥0.25

May 26

CEO

Zheng Long Yin (58 yo)

15.3yrs

Görev süresi

CN¥910,900

Tazminat

Mr. Zheng Long Yin is the General Manager and the Chairman of the Board of Directors at Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (formerly known as Anhui Shanhe Pharmaceutical Excipients Co., Ltd.)...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zheng Long Yin	Chairman & GM	15.3yrs	CN¥910.90k	27.11% CN¥ 776.2m
Qi Liu	Head of Finance & Secretary of the Board	4.4yrs	CN¥400.90k	0.028% CN¥ 800.1k
Dao Cai Song	Deputy GM & Non-Independent Director	6.3yrs	CN¥650.90k	0.091% CN¥ 2.6m
Hanfang Lei	Deputy GM & Director	no data	CN¥533.60k	Veri yok

6.3yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim: 300452 'un yönetim ekibi deneyimli ve deneyimlidir ( 6.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zheng Long Yin	Chairman & GM	15.3yrs	CN¥910.90k	27.11% CN¥ 776.2m
Dao Cai Song	Deputy GM & Non-Independent Director	3.3yrs	CN¥650.90k	0.091% CN¥ 2.6m
Hanfang Lei	Deputy GM & Director	4.3yrs	CN¥533.60k	Veri yok
Hong Wang	Independent Director	less than a year	Veri yok	Veri yok
Yuan Hui Li	Employee Representative of Supervisory Board	15.3yrs	Veri yok	Veri yok
Jian Ping Zhou	Independent Director	3.3yrs	CN¥60.00k	Veri yok
Lu Liu	Non-Independent Director	3.3yrs	Veri yok	Veri yok
Ping Lin	Independent Director	3.3yrs	CN¥60.00k	Veri yok
Yong Bi	Chairman of the Supervisory Board	3.3yrs	Veri yok	Veri yok
Chuanzhen Wang	Shareholder Supervisor	less than a year	Veri yok	Veri yok

3.3yrs

Ortalama Görev Süresi

52.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 300452 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.3 yıldır).

Anhui Sunhere Pharmaceutical ExcipientsLtd Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Announces Executive Appointments

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd., Annual General Meeting, May 16, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.15 in 3Q 2023)

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 27%

Anhui Sunhere Pharmaceutical ExcipientsLtd's (SZSE:300452) Earnings Are Weaker Than They Seem

Second quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.17 in 2Q 2023)

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Announces Executive Appointments

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024

Anhui Sunhere Pharmaceutical ExcipientsLtd (SZSE:300452) Has Affirmed Its Dividend Of CN¥0.25

Dividend of CN¥0.25 announced

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd., Annual General Meeting, May 16, 2024

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Proposes Final Cash Dividend for 2023

First quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.21 in 1Q 2023)

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SZSE:300452) announces an Equity Buyback for CNY 32 million worth of its shares.

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SZSE:300452) announces an Equity Buyback for CNY 32 million worth of its shares.

Investor sentiment deteriorates as stock falls 16%

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.12 in 3Q 2022)

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.13 in 2Q 2022)

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 17 May 2023

Full year 2022 earnings: EPS and revenues miss analyst expectations

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. announced a financing transaction

Investor sentiment improved over the past week

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.078 in 3Q 2021)

Investor sentiment improved over the past week

Now 21% undervalued

Second quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.099 in 2Q 2021)

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on May 26, 2022

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Approves Dividend for 2021

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

High number of new and inexperienced directors

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Proposes Cash Dividend for the Year 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.10 (vs CN¥0.10 in 3Q 2020)

High number of new and inexperienced directors

Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.15 in 2Q 2020)

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Announces for the Year 2021, Payable on 20 May 2020

Full year 2020 earnings released: EPS CN¥0.53 (vs CN¥0.47 in FY 2019)

New 90-day low: CN¥15.38

New 90-day low: CN¥17.42

Market bids up stock over the past week

New 90-day low: CN¥18.95

Market pulls back on stock over the past week

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. to Report Q3, 2020 Results on Oct 27, 2020

New 90-day low: CN¥21.31

Third quarter earnings released

New 90-day high - CN¥28.39

Earnings released

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥27.97

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş